<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Skull base giant cell tumors uncovered: Clinical challenges and evolving treatment strategies-A case and literature review

dc.contributor.authorSoto, Gervith Reyes
dc.contributor.authorRangel, Carlos Castillo
dc.contributor.authorBozkurt, Ismail
dc.contributor.authorMoreno, Daniel Alejandro Vega
dc.contributor.authorRosario, Andreina Rosario
dc.contributor.authorOzoria, Ruben Dario Bleubar
dc.contributor.authorRamirez, Manuel De Jesus Encarnacion
dc.date.accessioned2026-10-09T21:48:35Z
dc.date.issued2025
dc.departmentYüksek İhtisas Üniversitesi
dc.description.abstractBackground: Giant cell tumor (GCT) is a low frequency, benign neoplasm that generally produces lytic lesions. It mainly affects women in the third to fifth decade of life. Its most frequently reported location is in the temporal bone, especially the petrous portion, followed by the sphenoid. There are multiple lines of treatment; however, surgical management remains the standard treatment. Methods: An 18-year-old man presented with diplopia. Through imaging studies and biopsy, he was diagnosed with a GCT of the cranial base. The patient was managed surgically on two occasions and with complementary treatment with denosumab, which achieved complete remission and a total reduction in tumor volume. A systematic review of previously published studies was conducted. Results: We identified a total of 128 records through database searching from PubMed, Medline, and Scopus. The screening process left 23 records for detailed review. Upon further evaluation, nine non-research letters or commentaries were excluded, resulting in 15 full-text articles being included in the final review. Conclusions: GCTs have benign histological characteristics; however, the bony lytic destruction makes their management difficult. The main stray treatment modality continues to be surgery. However, as presented in our case supported with multiple studies adjuvant treatment with denosumab yields good responses.
dc.identifier.doi10.1016/j.wnsx.2025.100527
dc.identifier.issn2590-1397
dc.identifier.orcid0000-0002-6719-5522
dc.identifier.orcid0000-0001-7155-2062
dc.identifier.scopus2-s2.0-105016373900
dc.identifier.scopusqualityQ3
dc.identifier.urihttps://doi.org/10.1016/j.wnsx.2025.100527
dc.identifier.urihttps://hdl.handle.net/20.500.12794/3583
dc.identifier.volume28
dc.identifier.wosWOS:001577600500001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynak.digerEmerging Sources Citation Index (ESCI)
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofWorld Neurosurgery-X
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.relation.sdgGoal-03: Good Health and Well-Being
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260922
dc.subjectGiant Cell Tumor
dc.subjectSkull Base
dc.subjectDenosumab
dc.titleSkull base giant cell tumors uncovered: Clinical challenges and evolving treatment strategies-A case and literature review
dc.typeReview Article

Files